Cardiac magnetic resonance imaging in the evaluation of the late effects of anthracyclines among long-term survivors of childhood cancer

Journal of the American College of Cardiology

Volumn 61, Issue 14, 2013, Pages 1539-1547

  Ylänen, Kaisa ^a   Poutanen, Tuija ^a   Savikurki Heikkilä, Päivi ^a   Rinta Kiikka, Irina ^a   Eerola, Anneli ^a   Vettenranta, Kim ^a  

^a TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

Author keywords

anthracycline; dysfunction; fibrosis; late gadolinium enhancement; magnetic resonance imaging

Indexed keywords

BISOPROLOL; DAUNORUBICIN; DOXORUBICIN; ENALAPRIL; GADOTERATE MEGLUMINE; IDARUBICIN; MITOXANTRONE;

ADOLESCENT; AGE DISTRIBUTION; ARTICLE; CANCER SURVIVOR; CARDIOVASCULAR MAGNETIC RESONANCE; CARDIOVASCULAR PARAMETERS; CHILD; CHILDHOOD CANCER; DRUG EFFICACY; DRUG INDUCED DISEASE; FEMALE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE FIBROSIS; HEART RIGHT VENTRICLE EJECTION FRACTION; HEART RIGHT VENTRICLE FUNCTION; HUMAN; IMAGE ANALYSIS; IMAGE DISPLAY; INFANT; MALE; MALIGNANT NEOPLASTIC DISEASE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEX DIFFERENCE; SURVIVAL TIME; TREATMENT OUTCOME;

ADOLESCENT; AGE FACTORS; ANTHRACYCLINES; CHILD; COHORT STUDIES; FEMALE; FIBROSIS; FINLAND; HUMANS; MAGNETIC RESONANCE IMAGING, CINE; MALE; MYOCARDIUM; NEOPLASMS; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SEX FACTORS; SURVIVAL RATE; SURVIVORS; VENTRICULAR DYSFUNCTION, LEFT; VENTRICULAR DYSFUNCTION, RIGHT;

EID: 84875786203     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2013.01.019     Document Type: Article

References (41)

1. S.E. Lipshultz, S.D. Colan, R.D. Gelber, A.R. Perez-Atayde, S.E. Sallan, S.P. Sanders Late cardiac effects of doxorubicin therapy for acute lymphoblastic leukemia in childhood N Engl J Med 324 1991 808 815
2. D.A. Mulrooney, M.W. Yeazel, T. Kawashima Cardiac outcomes in a cohort of adult survivors of childhood and adolescent cancer: retrospective analysis of the childhood cancer survivor study cohort BMJ 339 2009 b4606
3. J.G. Blanco, C.L. Sun, W. Landier Anthracycline-related cardiomyopathy after childhood cancer: role of polymorphisms in carbonyl reductase genes - a report from the Children's Oncology Group J Clin Oncol 30 2012 1415 1421
4. L.C. Kremer, H.J. van der Pal, M. Offringa, E.C. van Dalen, P.A. Voute Frequency and risk factors of subclinical cardiotoxicity after anthracycline therapy in children: a systematic review Ann Oncol 13 2002 819 829
5. L.C. Kremer, E.C. van Dalen, M. Offringa, P.A. Voute Frequency and risk factors of anthracycline-induced clinical heart failure in children: a systematic review Ann Oncol 13 2002 503 512
6. S.M. Swain, F.S. Whaley, M.S. Ewer Congestive heart failure in patients treated with doxorubicin: a retrospective analysis of three trials Cancer 97 2003 2869 2879
7. G. Levitt, A. Anazodo, M. Burch, K. Bunch Cardiac or cardiopulmonary transplantation in childhood cancer survivors: an increasing need? Eur J Cancer 45 2009 3027 3034
8. J. Ganame, P. Claus, A. Uyttebroeck Myocardial dysfunction late after low-dose anthracycline treatment in asymptomatic pediatric patients J Am Soc Echocardiogr 20 2007 1351 1358
9. G.T. Armstrong, J.C. Plana, N. Zhang Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging J Clin Oncol 30 2012 2876 2884
10. N.G. Keenan, D.J. Pennell CMR of ventricular function Echocardiography 24 2007 185 193
11. American College of Cardiology Foundation Task Force on Expert Consensus, Documents W.G. Hundley, D.A. Bluemke et al. ACCF/ACR/AHA/NASCI/SCMR 2010 expert consensus document on cardiovascular magnetic resonance: a report of the American College of Cardiology Foundation Task Force on Expert Consensus Documents J Am Coll Cardiol 55 2010 2614 2662
12. F. Haddad, S.A. Hunt, D.N. Rosenthal, D.J. Murphy Right ventricular function in cardiovascular disease, part I: anatomy, physiology, aging, and functional assessment of the right ventricle Circulation 117 2008 1436 1448
13. S. Fratz, A. Schuhbaeck, C. Buchner Comparison of accuracy of axial slices versus short-axis slices for measuring ventricular volumes by cardiac magnetic resonance in patients with corrected tetralogy of Fallot Am J Cardiol 103 2009 1764 1769
14. D.M. Sado, A.S. Flett, J.C. Moon Novel imaging techniques for diffuse myocardial fibrosis Future Cardiol 7 2011 643 650
15. E. Wu, R.M. Judd, J.D. Vargas, F.J. Klocke, R.O. Bonow, R.J. Kim Visualisation of presence, location, and transmural extent of healed Q-wave and non-Q-wave myocardial infarction Lancet 357 2001 21 28
16. K.G. Ordovas, C.B. Higgins Delayed contrast enhancement on MR images of myocardium: past, present, future Radiology 261 2011 358 374
17. D.B. Sawyer, X. Peng, B. Chen, L. Pentassuglia, C.C. Lim Mechanisms of anthracycline cardiac injury: can we identify strategies for cardioprotection? Prog Cardiovasc Dis 53 2010 105 113
18. L.J. Steinherz, P.G. Steinherz, C. Tan Cardiac failure and dysrhythmias 6-19 years after anthracycline therapy: a series of 15 patients Med Pediatr Oncol 24 1995 352 361
19. D. Robbers-Visser, E. Boersma, W.A. Helbing Normal biventricular function, volumes, and mass in children aged 8 to 17 years J Magn Reson Imaging 29 2009 552 559
20. S. Sarikouch, B. Peters, M. Gutberlet Sex-specific pediatric percentiles for ventricular size and mass as reference values for cardiac MRI: assessment by steady-state free-precession and phase-contrast MRI flow Circ Cardiovasc Imaging 3 2010 65 76
21. J.M. Bland, D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 1986 307 310
22. A. Hadar, E. Sheiner, F. Press, A. Katz, M. Katz Dilated cardiomyopathy in a pregnant woman after doxorubicin and radiotherapy for Hodgkin's disease: a case report J Reprod Med 49 2004 401 403
23. M. Ryberg, D. Nielsen, G. Cortese, G. Nielsen, T. Skovsgaard, P.K. Andersen New insight into epirubicin cardiac toxicity: competing risks analysis of 1097 breast cancer patients J Natl Cancer Inst 100 2008 1058 1067
24. C.B. Higgins Which standard has the gold? J Am Coll Cardiol 19 1992 1608 1609
25. E. Belloni, F. De Cobelli, A. Esposito MRI of cardiomyopathy AJR Am J Roentgenol 191 2008 1702 1710
26. W.A. Helbing, S.A. Rebergen, C. Maliepaard Quantification of right ventricular function with magnetic resonance imaging in children with normal hearts and with congenital heart disease Am Heart J 130 1995 828 837
27. C.H. Lorenz The range of normal values of cardiovascular structures in infants, children, and adolescents measured by magnetic resonance imaging Pediatr Cardiol 21 2000 37 46
28. P.A. Cain, R. Ahl, E. Hedstrom Age and gender specific normal values of left ventricular mass, volume and function for gradient echo magnetic resonance imaging: a cross sectional study BMC Med Imaging 9 2009 2
29. K. Oberholzer, R.P. Kunz, M. Dittrich, M. Thelen [Anthracycline-induced cardiotoxicity: cardiac MRI after treatment for childhood cancer] ROFO Fortschr Geb Rontgenstr Nuklearmed 176 2004 1245 1250
30. M.H. Chen, S.D. Colan, L. Diller Cardiovascular disease: cause of morbidity and mortality in adult survivors of childhood cancers Circ Res 108 2011 619 628
31. M.J. Adams, S.R. Lipsitz, S.D. Colan Cardiovascular status in long-term survivors of Hodgkin's disease treated with chest radiotherapy J Clin Oncol 22 2004 3139 3148
32. J.C. Moon, W.J. McKenna, J.A. McCrohon, P.M. Elliott, G.C. Smith, D.J. Pennell Toward clinical risk assessment in hypertrophic cardiomyopathy with gadolinium cardiovascular magnetic resonance J Am Coll Cardiol 41 2003 1561 1567
33. R.G. Assomull, S.K. Prasad, J. Lyne Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy J Am Coll Cardiol 48 2006 1977 1985
34. D. Wadhwa, N. Fallah-Rad, D. Grenier Trastuzumab mediated cardiotoxicity in the setting of adjuvant chemotherapy for breast cancer: a retrospective study Breast Cancer Res Treat 117 2009 357 364
35. R.G. Assomull, D.J. Pennell, S.K. Prasad Cardiovascular magnetic resonance in the evaluation of heart failure Heart 93 2007 985 992
36. R. Wassmuth, S. Lentzsch, U. Erdbruegger Subclinical cardiotoxic effects of anthracyclines as assessed by magnetic resonance imaging-a pilot study Am Heart J 141 2001 1007 1013
37. R.D. Perel, R.E. Slaughter, W.E. Strugnell Subendocardial late gadolinium enhancement in two patients with anthracycline cardiotoxicity following treatment for Ewing's sarcoma J Cardiovasc Magn Reson 8 2006 789 791
38. W. Machann, M. Beer, M. Breunig Cardiac magnetic resonance imaging findings in 20-year survivors of mediastinal radiotherapy for Hodgkin's disease Int J Radiat Oncol Biol Phys 79 2011 1117 1123
39. E.C. van Dalen, H.J. van der Pal, W.E. Kok, H.N. Caron, L.C. Kremer Clinical heart failure in a cohort of children treated with anthracyclines: a long-term follow-up study Eur J Cancer 42 2006 3191 3198
40. A.S. Flett, M.P. Hayward, M.T. Ashworth Equilibrium contrast cardiovascular magnetic resonance for the measurement of diffuse myocardial fibrosis: Preliminary validation in humans Circulation 122 2010 138 144
41. B.N. Bernaba, J.B. Chan, C.K. Lai, M.C. Fishbein Pathology of late-onset anthracycline cardiomyopathy Cardiovasc Pathol 19 2010 308 311